v3.26.1
Restatement of Previously Issued Financial Statements - Schedule of Restated Consolidated Statement of Operations (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Schedule of Restated Consolidated Statement of Operations [Line Items]    
Revenues, net $ 1,071 $ 1,257
Cost of revenues 1,041 443
Gross profit 30 814
Operating expenses    
Research and development 1,131 484
Sales and marketing 3,061 245
General and administrative 8,209 4,014
Total operating expenses 12,401 4,743
Loss from operations (12,371) (3,929)
Other expenses    
Other income (loss) (1,181) (25,965)
Total other expenses 2,218 (25,636)
Loss before income tax expense (10,153) (29,565)
Consolidated net loss (10,153) (29,565)
Net loss attributable to common stockholders $ (10,145) $ (29,544)
Basic net loss per share of common stock (in Dollars per share) $ (0.05) $ (0.31)
Diluted net loss per share of common stock (in Dollars per share) $ (0.05) $ (0.31)
As Previously Reported [Member]    
Schedule of Restated Consolidated Statement of Operations [Line Items]    
Revenues, net $ 1,147  
Cost of revenues 547 $ 123
Gross profit [1] 600 1,134
Operating expenses    
Research and development 448  
Sales and marketing 188  
General and administrative 11,773 4,303
Total operating expenses [1] 12,409 5,032
Loss from operations [1] (11,809) (3,898)
Other expenses    
Other income (loss)
Total other expenses [1] 3,399 329
Loss before income tax expense [1] (8,410) (3,569)
Consolidated net loss [1] (8,410) (3,569)
Net loss attributable to common stockholders [1] $ (8,402) $ (3,548)
Basic net loss per share of common stock (in Dollars per share) $ (0.04) $ (0.04)
Diluted net loss per share of common stock (in Dollars per share) $ (0.04) $ (0.04)
Restatement Adjustment [Member]    
Schedule of Restated Consolidated Statement of Operations [Line Items]    
Revenues, net $ (76)  
Cost of revenues 494 $ 320
Gross profit [1] (570) (320)
Operating expenses    
Research and development 683  
Sales and marketing 2,873  
General and administrative (3,564) (289)
Total operating expenses [1] (8) (289)
Loss from operations [1] (562) (31)
Other expenses    
Other income (loss) (1,181) (25,965)
Total other expenses [1] (1,181) (25,965)
Loss before income tax expense [1] (1,743) (25,996)
Consolidated net loss [1] (1,743) (25,996)
Net loss attributable to common stockholders [1] (1,743) (25,996)
As Restated [Member]    
Schedule of Restated Consolidated Statement of Operations [Line Items]    
Revenues, net 1,071  
Cost of revenues 1,041 443
Gross profit [1] 30 814
Operating expenses    
Research and development 1,131  
Sales and marketing 3,061  
General and administrative 8,209 4,014
Total operating expenses [1] 12,401 4,743
Loss from operations [1] (12,371) (3,929)
Other expenses    
Other income (loss) (1,181) (25,965)
Total other expenses [1] 2,218 (25,636)
Loss before income tax expense [1] (10,153) (29,565)
Consolidated net loss [1] (10,153) (29,565)
Net loss attributable to common stockholders [1] $ (10,145) $ (29,544)
Basic net loss per share of common stock (in Dollars per share) $ (0.05) $ (0.31)
Diluted net loss per share of common stock (in Dollars per share) $ (0.05) $ (0.31)
[1] Represents the downstream effects of the identified restatement adjustments and other individually immaterial changes.